Skip to content
10-Q

Quarterly Report

PROCEPT BioRobotics Corporation PRCT

0001588978-25-000033

← back to feed
Filed
May 2, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 25, 2025 55.33M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $51.5M
Long Term Debt Q1 2025 · Dec 31, 2024 $51.47M
Current Liabilities Q1 2025 · Mar 31, 2025 $52.06M
Current Liabilities Q1 2025 · Dec 31, 2024 $53.13M
Total Liabilities Q1 2025 · Mar 31, 2025 $130.22M
Total Liabilities Q1 2025 · Dec 31, 2024 $131.8M
Current Assets Q1 2025 · Mar 31, 2025 $465.79M
Current Assets Q1 2025 · Dec 31, 2024 $481.84M
Total Assets Q1 2025 · Mar 31, 2025 $519.38M
Total Assets Q1 2025 · Dec 31, 2024 $534.02M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $333.73M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $225.58M
Shares Diluted Q1 2025 · Mar 31, 2024 51.01M sh
Capex Q1 2025 · Mar 31, 2024 $1.95M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$32.29M
Stockholders Equity Q1 2025 · Mar 31, 2024 $264.05M
Stockholders Equity Q1 2025 · Dec 31, 2023 $280.75M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.51
Eps Basic Q1 2025 · Mar 31, 2024 −$0.51
Sga Expense Q1 2025 · Mar 31, 2024 $39.6M
Rd Expense Q1 2025 · Mar 31, 2024 $13.08M
Net Income Q1 2025 · Mar 31, 2024 −$25.96M
Operating Income Q1 2025 · Mar 31, 2024 −$27.65M
Gross Profit Q1 2025 · Mar 31, 2024 $25.03M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $19.51M
Revenue Q1 2025 · Mar 31, 2024 $44.54M